However, the administration of ODZ10117 suppressed the tumor population and levels of active STAT3 and tumor growth-associated factors and increased the level of active caspase-3 (Figure 6D), indicating the effective anti-tumor effect of ODZ10117. The gene discussed is CASP3; the disease is neoplasm.